Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Eva Compérat, MD, PhD, Hôpital Tenon and Sorbonne University, Paris, France, outlines remaining challenges in the treatment and management of patients with urothelial carcinoma, including understanding markers of outcomes for patients with T1 tumors, as well as sub staging in T1 tumors. This interview took place at the PROSCA/BLADDR 2021 congress.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.